Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EBS
EBS logo

EBS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Emergent BioSolutions Inc (EBS) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

No data

No data

Growth

Profitability

Efficiency

Wall Street analysts forecast EBS stock price to rise
1 Analyst Rating
Wall Street analysts forecast EBS stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 7.940
sliders
Low
15
Averages
15
High
15
Current: 7.940
sliders
Low
15
Averages
15
High
15
H.C. Wainwright
Buy
downgrade
$15 -> $12
AI Analysis
2026-03-09
Reason
H.C. Wainwright
Price Target
$15 -> $12
AI Analysis
2026-03-09
downgrade
Buy
Reason
H.C. Wainwright lowered the firm's price target on Emergent BioSolutions to $12 from $15 and keeps a Buy rating on the shares following the earnings miss. The firm cites lowered earnings expectations for the target cut.
JPMorgan
NULL -> Overweight
maintain
2025-12-02
Reason
JPMorgan
Price Target
2025-12-02
maintain
NULL -> Overweight
Reason
JPMorgan raised the firm's price target on Erste Group Bank to EUR 107 from EUR 102 and keeps an Overweight rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for EBS
Unlock Now

People Also Watch